BR9812385A - Formulações parasiticidas - Google Patents

Formulações parasiticidas

Info

Publication number
BR9812385A
BR9812385A BR9812385-8A BR9812385A BR9812385A BR 9812385 A BR9812385 A BR 9812385A BR 9812385 A BR9812385 A BR 9812385A BR 9812385 A BR9812385 A BR 9812385A
Authority
BR
Brazil
Prior art keywords
formulations
parasiticidal
parasiticidal formulations
parasiticid
administer
Prior art date
Application number
BR9812385-8A
Other languages
English (en)
Inventor
Hiep Huatan
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of BR9812385A publication Critical patent/BR9812385A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Abstract

Patente de Invenção:<B>"FORMULAçõES PARASITICIDAS"<D>. A invenção refere-se a um implante sólido compreendendo pelo menos um composto parasiticida com uma solubilidade aquosa reduzida; e excipientes para formação de comprimidos incluindo um agente de volume. Os implantes de acordo com a invenção são convenientes para administrar e proporcionam uma proteção prolongada contra os parasitas.
BR9812385-8A 1997-09-23 1998-09-04 Formulações parasiticidas BR9812385A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations
PCT/EP1998/005720 WO1999015166A1 (en) 1997-09-23 1998-09-04 Parasiticidal formulations

Publications (1)

Publication Number Publication Date
BR9812385A true BR9812385A (pt) 2000-09-12

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812385-8A BR9812385A (pt) 1997-09-23 1998-09-04 Formulações parasiticidas

Country Status (13)

Country Link
EP (1) EP1014970A1 (pt)
JP (1) JP2001517622A (pt)
AP (1) AP9801350A0 (pt)
AR (1) AR013509A1 (pt)
AU (1) AU9742298A (pt)
BR (1) BR9812385A (pt)
CA (1) CA2304283A1 (pt)
GT (1) GT199800149A (pt)
MA (1) MA24655A1 (pt)
PA (1) PA8459501A1 (pt)
PE (1) PE117199A1 (pt)
TN (1) TNSN98175A1 (pt)
WO (1) WO1999015166A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
WO2001037811A1 (en) * 1999-11-22 2001-05-31 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (de) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
EP3634583A4 (en) * 2017-06-06 2021-03-03 Merck Sharp & Dohme Corp. LONG-ACTION IMPLANT FOR THE TREATMENT OF INFECTIOUS DISEASES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (en) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectins as growth promotant agents
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
MA24655A1 (fr) 1999-04-01
CA2304283A1 (en) 1999-04-01
GT199800149A (es) 2000-03-15
AR013509A1 (es) 2000-12-27
JP2001517622A (ja) 2001-10-09
WO1999015166A1 (en) 1999-04-01
TNSN98175A1 (fr) 2005-03-15
PA8459501A1 (es) 2000-05-24
PE117199A1 (es) 1999-11-20
AP9801350A0 (en) 2000-03-17
EP1014970A1 (en) 2000-07-05
AU9742298A (en) 1999-04-12

Similar Documents

Publication Publication Date Title
BR9914251A (pt) Formulações orais de liberação sustentada
BR0015188A (pt) Composições farmacêuticas
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
ES2162319T3 (es) Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer.
WO2000041681A3 (de) ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN
NO20016107L (no) Mesalazin-kontrollert frigivelse orale farmasöytiske sammensetninger
DK1792610T3 (da) Terapeutiske bioadhæsive systemet med langvarig frigivelse
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
CA2385890A1 (en) Controlled release compositions comprising nimesulide
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
BR9810495A (pt) Composição farmacêutica
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
BR9812385A (pt) Formulações parasiticidas
BR0012696A (pt) Composição oftálmica
NO994431L (no) Ny formulering
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
DE60128100D1 (de) Analgetisches arzneimittel
WO1999061014A3 (en) Compositions and methods employing r(-) fluoxetine and other active ingredients
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
IT1306147B1 (it) Derivati di principi attivi ad attivita&#39; terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
BR9707770C1 (pt) Tifluzamida com eficácia aperfeiçoada
GEP20043377B (en) Pharmaceutical Complex
SE9902742D0 (sv) New pharmaceutical formultion

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 8A E 9A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1912 DE 28/08/2007.